HCM
MEDS

Heights Capital Management’s DataMeds AI MEDS Stock Holding History

Heights Capital Management’s Portfolio MEDS Stock Details MEDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-58,342
Closed -$2.59M – 229
2025
Q3 		$2.59M Buy
+58,342
New +$3.08M 0.74% 29

Other funds holding MEDS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
VFIC
Valley Forge Investment Consultants Audubon, Pennsylvania $388M AUM 22.18% 1-Year Est. Return

Heights Capital Management's MEDS Position: Q4 2025 in Review

Heights Capital Management sold out of DataMeds AI (MEDS) in Q4 2025, closing a stake of 58,342 shares — an estimated $2.59M sold.

Heights Capital Management first reported a position in MEDS in Q3 2025 and held it in 1 quarter. The position peaked at $2.59M in Q3 2025. 19 funds tracked by Wall St. Rank hold MEDS as of Q4 2025.

  • Heights Capital Management reported no remaining DataMeds AI position as of Q4 2025 after selling out during the quarter.
  • Heights Capital Management sold 58,342 DataMeds AI shares in Q4 2025, an estimated $2.59M.
  • Heights Capital Management first reported a position in DataMeds AI in Q3 2025 and held it in 1 quarter.
  • Heights Capital Management's DataMeds AI position peaked at $2.59M in Q3 2025.
  • 19 funds tracked by Wall St. Rank held DataMeds AI as of Q4 2025.

Based on Heights Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.